Videos

These pharmacies can use electronic medical records to work more directly with providers, monitoring adverse medication effects and assessment schedules and being more tuned into patient needs.

Kimberly Westrich, MA, discussed value assessment tools and how they can help make key decisions in health care spending.

Laura Chambers, DO, drives a conversation surrounding the impact of misinformation on gynecologic cancers that is spread through social media.

Celebrate pharmacy technicians and their crucial role in the pharmacy ecosystem.

Margaret Ryman, BS, PharmD, BCPS, vice president of Health Systems at McKesson, discussed how she has seen the pharmacy field change and how she is celebrating this American Pharmacists Month.

Sindhuja Merugu, pharmacy technician at Health Mart Family Pharmacy discusses the role of the pharmacy technician, how the pharmacy technician profession has changed, and what is to come in the field.

Dr Moore examines findings from the NATALEE trial.

The pharmacist’s role in addressing treatment failure for patients receiving CDK4/6 inhibitors is examined.

Rose DiMarco, PharmD, BCPS, BCOP, addresses strategies to maximize patient adherence to CDK4/6 inhibitor therapy.

Karline Peal, MBA of Vanderbilt Ingram Cancer Center discusses the positive impact technology has had in health care and how it can be implemented in the future.

Jacinda Abdul-Mutakabbir, PharmD, MPH, AAHIVP, discusses being the second pharmacist in IDSA history to receive a society award and what this means not only for her, but for the field.

Jennifer Mathieu, MA from the Academy of Managed Care Pharmacy (AMCP) discusses what to expect from AMCP Nexus 2023 and some of the sessions she is looking forward to.

With walkouts across the country and other efforts to raise public awareness, pharmacists are working to find solutions to understaffing and workload challenges.

Within this care model, pharmacists can serve an important role in caring for patients, whether it is identifying adverse medication interactions or pushing patients to seek additional support.

Cheri Schmit, RPh, Senior Manager of clinical Solutions at Cardinal Health, discusses the role of the pharmacists, how the pharmacy profession has changed, and what is to come in the field.

Heather Moore, CPP, PharmD, BCOP, highlights the impact of pharmacists in adverse effect profile management for CDK4/6 inhibitors.

A description of the SONIA study is provided by Heather Moore, CPP, PharmD.

Hormone therapy in metastatic breast cancer management is examined by key opinion leaders.

With World Standards Week on October 10 to 12, 2023, it is a key time to assess preparation for the official date for revised USP General Chapters <795> and <797> on compounding, as well as the associated USP General Chapter <800> on the handling of hazardous drugs in healthcare settings.

Naveen Mansukhani, BPharm, National Operations Director for Cardinal Health Retail Pharmacy Services, discussed how he is celebrating American Pharmacists Month.

Laura Akers, PharmD, RPh/CPh, MBA, BCOP discusses the role of the pharmacist, how the pharmacy profession has changed, and what is to come in the field.

The manager of patient support services at St. Luke’s Cancer Center discusses the significance of Reaching Out for Healthy Women and how female patients can receive support from this initiative.

In addition to the annual flu vaccines, COVID-19 boosters and RSV vaccines present new opportunities for pharmacists to advise patients.

Craig Dolan, PharmD, MBA, BSPharm discusses the role of the pharmacist, how the pharmacy profession has changed, and what is to come in the field.

Expert explains how the role of pharmacists in myelofibrosis treatment has evolved significantly over the past decade.

Ryan Haumschild, PharmD, MS, MBA, leads drives a conversation surrounding the impact of CDK4/6 inhibitors in treatment of metastatic breast cancer.

A panel of medical experts begin a discussion surrounding key updates in treatment and management of HR+/HER2- metastatic breast cancer.

Ruben A. Mesa, MD, FACP, discusses the results of the SIMPLIFY-1 and MOMENTUM trials and how the data led to the approval of momelotinib to treat intermediate or high-risk myelofibrosis in adult patients with anemia.

Dr Moore provides a detailed summary of the scope and findings from the TROPiCS-02 study.

Pharmacists are experts at juggling shortages of all kinds, however, and L’Altrelli said they are crucial team members regarding opioid access challenges.